What is a stock summary page? Click here for an overview.
Business Description
NFL Biosciences SA
ISIN : FR0014003XT0
Compare
Compare
Traded in other countries / regions
ALNFL.France82F.Germany IPO Date
2021-07-15Description
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 70.68 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -112.5 | |||||
| 3-Year EPS without NRI Growth Rate | -108.9 | |||||
| 3-Year Book Growth Rate | 14 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.02 | |||||
| 9-Day RSI | 33.98 | |||||
| 14-Day RSI | 36.76 | |||||
| 3-1 Month Momentum % | -12.34 | |||||
| 6-1 Month Momentum % | -12.34 | |||||
| 12-1 Month Momentum % | -37.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.74 | |||||
| Quick Ratio | 1.74 | |||||
| Cash Ratio | 1.38 | |||||
| Days Payable | 399.52 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.7 | |||||
| Shareholder Yield % | 0.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -156.44 | |||||
| ROA % | -48.78 | |||||
| ROIC % | -164.69 | |||||
| 3-Year ROIIC % | -376.93 | |||||
| ROC (Joel Greenblatt) % | -5928.36 | |||||
| ROCE % | -174.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 1.19 | |||||
| PB Ratio | 6.8 | |||||
| Price-to-Tangible-Book | 6.98 | |||||
| EV-to-EBIT | -4.29 | |||||
| EV-to-EBITDA | -4.38 | |||||
| Price-to-Net-Current-Asset-Value | 7.33 | |||||
| Price-to-Net-Cash | 14.66 | |||||
| Earnings Yield (Greenblatt) % | -23.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NFL Biosciences SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.278 | ||
| Beta | 0.9 | ||
| 3-Year Sharpe Ratio | 0.44 | ||
| 3-Year Sortino Ratio | 0.86 | ||
| Volatility % | 63.72 | ||
| 14-Day RSI | 36.76 | ||
| 14-Day ATR (€) | 0.043888 | ||
| 20-Day SMA (€) | 1.5653 | ||
| 12-1 Month Momentum % | -37.46 | ||
| 52-Week Range (€) | 1.466 - 2.89 | ||
| Shares Outstanding (Mil) | 9.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NFL Biosciences SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NFL Biosciences SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
NFL Biosciences SA Frequently Asked Questions
What is NFL Biosciences SA(FRA:82F)'s stock price today?
The current price of FRA:82F is €1.47. The 52 week high of FRA:82F is €2.89 and 52 week low is €1.47.
When is next earnings date of NFL Biosciences SA(FRA:82F)?
The next earnings date of NFL Biosciences SA(FRA:82F) is .
Does NFL Biosciences SA(FRA:82F) pay dividends? If so, how much?
NFL Biosciences SA(FRA:82F) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers